Johnson & Johnson (XSWX:JNJ)
CHF 205.1 -3.8 (-1.82%) Market Cap: 494.51 Bil Enterprise Value: 521.16 Bil PE Ratio: 29.35 PB Ratio: 7.52 GF Score: 76/100

Johnson & Johnson at Consumer Analyst Group of New York Conference Transcript

Feb 19, 2019 / 02:00PM GMT
Release Date Price: CHF137.78 (+1.16%)
Andrew Lazar
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

Good morning. Thank you for rejoining us. We're fortunate to have with us once again this year the management team of Johnson & Johnson's Worldwide Consumer Group. Specifically for purposes of this presentation, Alison Lewis, who is Chief Marketing Officer of J&J Consumer. Johnson & Johnson's Consumer business delivered $13.9 billion in global sales in 2018, returning to above-market growth, an acceleration that was fueled by innovative category-growing products as well as geographic expansion of multiple brands. Since last year's presentation, the company also announced the acquisitions of 2 new companies in fast-growing categories, Zarbee's in the nationally based OTC space and Dr.Ci:Labo in the premium beauty space. So please join me in welcoming Alison and J&J to the conference.

Alison Lewis
Johnson & Johnson Consumer Inc. - Global CMO

Thank you. So it's great to be here with all of you again this year to share a little bit more about Johnson &

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot